
### [NCIT:C4275](http://purl.obolibrary.org/obo/NCIT_C4275)
**Label:** Malignant Phyllodes Tumor

**Subclasses:** [NCIT:C4504](http://purl.obolibrary.org/obo/NCIT_C4504) (Malignant Breast Phyllodes Tumor), [NCIT:C5531](http://purl.obolibrary.org/obo/NCIT_C5531) (Malignant Prostate Phyllodes Tumor), [NCIT:C128165](http://purl.obolibrary.org/obo/NCIT_C128165) (Malignant Vulvar Phyllodes Tumor), 

**Class expressions from DL-Learner:**

- [NCIT:C54710](http://purl.obolibrary.org/obo/NCIT_C54710) (Mesenchymal Metaplasia) 64.73%
- [NCIT:C54710](http://purl.obolibrary.org/obo/NCIT_C54710) (Mesenchymal Metaplasia) and (not ([NCIT:C38171](http://purl.obolibrary.org/obo/NCIT_C38171) (PKCbeta1 Messenger RNA Overexpression))) 64.73%
- [NCIT:C54710](http://purl.obolibrary.org/obo/NCIT_C54710) (Mesenchymal Metaplasia) and (not ([NCIT:C38170](http://purl.obolibrary.org/obo/NCIT_C38170) (LMO2 Messenger RNA Overexpression))) 64.73%
- [NCIT:C54710](http://purl.obolibrary.org/obo/NCIT_C54710) (Mesenchymal Metaplasia) and (not ([NCIT:C38169](http://purl.obolibrary.org/obo/NCIT_C38169) (A-myb Messenger RNA Overexpression))) 64.73%
- [NCIT:C54710](http://purl.obolibrary.org/obo/NCIT_C54710) (Mesenchymal Metaplasia) and (not ([NCIT:C38168](http://purl.obolibrary.org/obo/NCIT_C38168) (BCL-6 Messenger RNA Overexpression))) 64.73%
- [NCIT:C54710](http://purl.obolibrary.org/obo/NCIT_C54710) (Mesenchymal Metaplasia) and (not ([NCIT:C38167](http://purl.obolibrary.org/obo/NCIT_C38167) (CD10 Messenger RNA Overexpression))) 64.73%
- [NCIT:C54710](http://purl.obolibrary.org/obo/NCIT_C54710) (Mesenchymal Metaplasia) and (not ([NCIT:C38158](http://purl.obolibrary.org/obo/NCIT_C38158) (Metachronous Wilms Tumor))) 64.73%
- [NCIT:C54710](http://purl.obolibrary.org/obo/NCIT_C54710) (Mesenchymal Metaplasia) and (not ([NCIT:C38157](http://purl.obolibrary.org/obo/NCIT_C38157) (Metachronous Osteosarcoma))) 64.73%
- [NCIT:C54710](http://purl.obolibrary.org/obo/NCIT_C54710) (Mesenchymal Metaplasia) and (not ([NCIT:C38155](http://purl.obolibrary.org/obo/NCIT_C38155) (Recurrent Disease))) 64.73%
- [NCIT:C54710](http://purl.obolibrary.org/obo/NCIT_C54710) (Mesenchymal Metaplasia) and (not ([NCIT:C38111](http://purl.obolibrary.org/obo/NCIT_C38111) (Skin Sarcomatoid Basal Cell Carcinoma))) 64.73%
- [NCIT:C54710](http://purl.obolibrary.org/obo/NCIT_C54710) (Mesenchymal Metaplasia) and (not ([NCIT:C38110](http://purl.obolibrary.org/obo/NCIT_C38110) (Skin Signet Ring Cell Basal Cell Carcinoma))) 64.73%
- [NCIT:C54710](http://purl.obolibrary.org/obo/NCIT_C54710) (Mesenchymal Metaplasia) and (not ([NCIT:C38107](http://purl.obolibrary.org/obo/NCIT_C38107) (Dedifferentiated Dermatofibrosarcoma Protuberans))) 64.73%
- [NCIT:C54710](http://purl.obolibrary.org/obo/NCIT_C54710) (Mesenchymal Metaplasia) and (not ([NCIT:C38106](http://purl.obolibrary.org/obo/NCIT_C38106) (Myxoid Dermatofibrosarcoma Protuberans))) 64.73%
- [NCIT:C54710](http://purl.obolibrary.org/obo/NCIT_C54710) (Mesenchymal Metaplasia) and (not ([NCIT:C38043](http://purl.obolibrary.org/obo/NCIT_C38043) (Typhlitis))) 64.73%
- [NCIT:C54710](http://purl.obolibrary.org/obo/NCIT_C54710) (Mesenchymal Metaplasia) and (not ([NCIT:C3804](http://purl.obolibrary.org/obo/NCIT_C3804) (Intradermal Nevus))) 64.73%


